BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 10631951)

  • 1. The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation.
    Alfonso C; Liljedahl M; Winqvist O; Surh CD; Peterson PA; Fung-Leung WP; Karlsson L
    Immunol Rev; 1999 Dec; 172():255-66. PubMed ID: 10631951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide exchange in MHC molecules.
    Jensen PE; Weber DA; Thayer WP; Westerman LE; Dao CT
    Immunol Rev; 1999 Dec; 172():229-38. PubMed ID: 10631949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonclassical MHC class II molecules.
    Alfonso C; Karlsson L
    Annu Rev Immunol; 2000; 18():113-42. PubMed ID: 10837054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading.
    Denzin LK; Cresswell P
    Cell; 1995 Jul; 82(1):155-65. PubMed ID: 7606781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered major histocompatibility complex class II peptide loading in H2-O-deficient mice.
    Perraudeau M; Taylor PR; Stauss HJ; Lindstedt R; Bygrave AE; Pappin DJ; Ellmerich S; Whitten A; Rahman D; Canas B; Walport MJ; Botto M; Altmann DM
    Eur J Immunol; 2000 Oct; 30(10):2871-80. PubMed ID: 11069069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.
    Vogt AB; Kropshofer H; Hämmerling GJ
    Hum Immunol; 1997 May; 54(2):170-9. PubMed ID: 9297535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport.
    Liljedahl M; Kuwana T; Fung-Leung WP; Jackson MR; Peterson PA; Karlsson L
    EMBO J; 1996 Sep; 15(18):4817-24. PubMed ID: 8890155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
    van Ham SM; Tjin EP; Lillemeier BF; Grüneberg U; van Meijgaarden KE; Pastoors L; Verwoerd D; Tulp A; Canas B; Rahman D; Ottenhoff TH; Pappin DJ; Trowsdale J; Neefjes J
    Curr Biol; 1997 Dec; 7(12):950-7. PubMed ID: 9382849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered antigen presentation in mice lacking H2-O.
    Liljedahl M; Winqvist O; Surh CD; Wong P; Ngo K; Teyton L; Peterson PA; Brunmark A; Rudensky AY; Fung-Leung WP; Karlsson L
    Immunity; 1998 Feb; 8(2):233-43. PubMed ID: 9492004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
    Karlsson L
    Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM.
    Robbins NF; Hammond C; Denzin LK; Pan M; Cresswell P
    Hum Immunol; 1996 Jan; 45(1):13-23. PubMed ID: 8655355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
    Singh N; Van Kaer L
    J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What to do with HLA-DO/H-2O two decades later?
    Welsh R; Song N; Sadegh-Nasseri S
    Immunogenetics; 2019 Mar; 71(3):189-196. PubMed ID: 30683973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation by HLA-DO of MHC class II-restricted antigen processing.
    Denzin LK; Sant'Angelo DB; Hammond C; Surman MJ; Cresswell P
    Science; 1997 Oct; 278(5335):106-9. PubMed ID: 9311912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H2-Mbeta 1 and H2-Mbeta 2 heterodimers equally promote clip removal in I-A(q) molecules from autoimmune-prone DBA/1 mice.
    Walter W; Scheuer C; Loos M; Reichert TE; Maeurer MJ
    J Biol Chem; 2001 Apr; 276(14):11086-91. PubMed ID: 11148202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DM can partially replace the invariant chain for HLA-DR transport and surface expression in transfected endocrine epithelial cells.
    Serradell L; Muntasell A; Catálfamo M; Martí M; Costa M; de Préval C; Jaraquemada D
    Tissue Antigens; 1999 May; 53(5):447-58. PubMed ID: 10372540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
    Kropshofer H; Hämmerling GJ; Vogt AB
    Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.